foxo4-dri senolytic or senomorphic Targeting Senescence: A Review of Senolytics and Senomorphics in Anti-Aging Interventions The FOXO4 peptide in a
Pay in 4 interest-free payments of $5.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Live Spec
The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine Cellular Senescence in Health, Disease, and Lens Aging FOXO4 DRI: The Senolytic Peptide That Targets Zombie Cells and Aging Revolution Health & Wellness Senescence Inducers and Senolytics Pathways and Drugs Targeting Cellular Senescence[v1]
Store: www.ab-travaux.com · Domain: www.ab-travaux.com

























